Sally Susman, Executive Vice President and Chief Corporate Affairs Officer at Pfizer, gives an insider’s look at how quickly development of a safe Covid vaccine is coming along. The New York City-based pharmaceutical giant is working closely with nonprofits, government, and other private companies to solve the biggest problem facing the world today.
ABOUT OUR GUEST:
Sally Susman is Executive Vice President and Chief Corporate Affairs Officer at Pfizer. She is vice chair of The Pfizer Foundation and co-chair of Pfizer’s Political Action Committee.
Sally leads engagement with all of Pfizer’s external stakeholders overseeing global policy, communications, government relations, investor relations and the Chief Patient Office. Sally also heads the firm’s corporate responsibility group. Before joining Pfizer in 2007, Sally held roles at Estée Lauder Companies and the American Express Company. Earlier in her career, she spent eight years in government service focused on international trade issues.
Sally serves on the board of WPP plc, a world leader in advertising and marketing based in the U.K. and as co-chair of the board of The International Rescue Committee.
LINKS RELATED TO THIS EPISODE:
- Connect with Sally Susman on LinkedIn
- Follow Pfizer on Twitter
- Learn more about Pfizer’s COVID-19 vaccine efforts
- The Motley Fool: Another Reason to Believe Pfizer Could Have a Coronavirus Vaccine Ready in October
- MedCity News: Pfizer, Germany’s BioNTech release new data on Covid-19 vaccine
- STAT: In the race for a Covid-19 vaccine, Pfizer turns to a scientist with a history of defying skeptics — and getting results
- The Washington Post: Pfizer CEO says vaccine would require 2 doses and U.S. government would provide it for free